September 3, 2026, will mark the concluding day of several technology- and innovation-focused events being held across India, including the Genomics India Conference 2026 in Bengaluru, EV India Expo 2026 in Greater Noida and the Esri India User Conference 2026 in New Delhi.

The three events cover different areas of technology and industry — genomics and biotechnology, electric mobility and geographic information systems (GIS). Their final-day programmes will bring the respective events to a close after multi-day sessions and exhibitions.

Genomics India Conference in Bengaluru

The Genomics India Conference (GIC) 2026 is being held in Bengaluru, with the main conference scheduled for September 2 and 3. A pre-conference workshop was held on September 1. The event is taking place at the Dr Babu Rajendra Prasad International Convention Centre on the GKVK campus. 

The conference brings together participants from areas including genomics, biotechnology, healthcare, agriculture, artificial intelligence and data science. Its programme covers subjects such as clinical and human genomics, agricultural genomics, microbiome research, next-generation sequencing technologies and translational genomics.

September 3 will be the final day of the main conference.

EV India Expo Concludes in Greater Noida

The EV India Expo 2026 is being organised from September 1 to 3 at the India Expo Centre in Greater Noida, Uttar Pradesh. The official event website lists September 3 as the final day of the exhibition. 

The sixth edition of the exhibition focuses on electric and hybrid vehicles and related technologies. The event covers areas including electric vehicles, automotive components, battery management and storage systems, charging equipment, charging infrastructure, software and allied industries. 

The expo is scheduled to remain open from 10 am to 6 pm during the three-day event period, according to the organiser's official information. 

Esri India User Conference in New Delhi

The Esri India User Conference 2026 is taking place on September 2 and 3 at Hotel Pullman New Delhi Aerocity. The conference focuses on GIS and location-based technologies and is scheduled to conclude on September 3.

According to the official agenda, the conference includes sessions covering areas such as land, utilities and urban applications, along with paper presentations and other technical sessions. (Esri India)

Three Technology Events on One Date

Although the three events have different areas of focus, September 3 brings their schedules together as a common closing date.

GIC 2026 is centred on advances in genomics and biotechnology, the EV India Expo focuses on electric mobility and related infrastructure, while the Esri India User Conference is dedicated to GIS and location intelligence.

Together, the events highlight the range of technology-driven sectors currently hosting conferences and exhibitions in India.

A major breakthrough in human gene-editing research has brought the possibility of preventing inherited diseases a step closer to reality. Scientists at Columbia University have successfully edited the DNA of early-stage human embryos with an accuracy level not previously achieved. While researchers say the technology could one day help eliminate certain genetic disorders, the development has also reignited global ethical concerns about the future creation of so-called “designer babies.”

The study was led by geneticist Dieter Egli and focused on a newer gene-editing technique known as base editing. Unlike traditional CRISPR technology, which cuts DNA strands, base editing makes highly targeted changes to individual genetic letters. Researchers say this approach significantly reduces the risk of unintended genetic damage, a major challenge that has limited embryo-editing research in the past.

According to the research team, the technology is still experimental and not ready for clinical use. However, the findings mark an important step toward understanding whether inherited diseases could one day be corrected before birth.

More Precise Than Earlier Methods

The researchers targeted two genes during the experiment. One of them, PCSK9, is associated with cholesterol levels and the risk of heart disease, while the HBG gene plays a role in the production of fetal haemoglobin.

Using donated fertilised eggs and two-cell embryos, scientists introduced base-editing molecules and successfully modified both genes. In several cases, they were able to edit both targets simultaneously without causing the large-scale DNA damage that had been observed in earlier CRISPR-based experiments.

The achievement is particularly significant because previous attempts at editing human embryos often resulted in serious genetic disruptions, including chromosome loss and unintended mutations. Researchers say the latest results suggest base editing may offer a safer alternative.

Ethical Questions Return

The breakthrough has once again raised questions about how far gene-editing technology should be allowed to go. While scientists involved in the project emphasise that the goal is to prevent serious inherited diseases, critics warn that the same technology could eventually be used to select or enhance traits such as intelligence, height, appearance, or athletic ability.

The debate over human embryo editing intensified in 2018 when Chinese scientist He Jiankui claimed to have created genetically modified babies resistant to HIV. The experiment was widely condemned by the international scientific community, and He was later sentenced to prison by Chinese authorities.

Since then, many experts have argued that embryo editing remains too risky for clinical use due to concerns about safety, unintended mutations, and long-term health effects.

Potential Benefits for IVF Patients

Researchers believe the technology could eventually benefit couples undergoing IVF treatment. In some cases, embryos carrying disease-causing mutations are discarded because they are unsuitable for implantation. Gene editing may one day allow doctors to repair those mutations, increasing the number of viable embryos available to prospective parents.

Scientists involved in the study say future research will focus on reducing a problem known as mosaicism, where some cells within an embryo are edited while others remain unchanged. This remains one of the biggest barriers to clinical application.

Experts have also stressed that extensive testing, regulatory review, and public debate will be required before any human embryo gene-editing technology could be used in fertility clinics.